In vitro activity of ABT 773, a new ketolide antibiotic, against Chlamydia pneumoniae.
dc.contributor.author | Strigl, S | |
dc.contributor.author | Roblin, P M | |
dc.contributor.author | Reznik, T | |
dc.contributor.author | Hammerschlag, M R | |
dc.date.accessioned | 2023-06-30T17:07:23Z | |
dc.date.available | 2023-06-30T17:07:23Z | |
dc.date.issued | 2000-04 | |
dc.identifier.citation | Strigl S, Roblin PM, Reznik T, Hammerschlag MR. In vitro activity of ABT 773, a new ketolide antibiotic, against Chlamydia pneumoniae. Antimicrob Agents Chemother. 2000 Apr;44(4):1112-3. doi: 10.1128/AAC.44.4.1112-1113.2000. PMID: 10722526; PMCID: PMC89827. | en_US |
dc.identifier.issn | 0066-4804 | |
dc.identifier.pmid | 10722526 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12648/10351 | |
dc.description.abstract | The in vitro activities of ABT 773, telithromycin (HMR 3647), azithromycin, clarithromycin, erythromycin, and levofloxacin were tested against 20 strains of Chlamydia pneumoniae. The MIC at which 90% of the isolates were inhibited and the minimal bactericidal concentration at which 90% of the isolates were killed by ABT 773 were 0.015 microg/ml (range, 0.008 to 0.015 microg/ml). ABT 773 was the most active antibiotic tested in this study. | |
dc.language.iso | en | en_US |
dc.relation.url | https://journals.asm.org/doi/epub/10.1128/aac.44.4.1112-1113.2000 | en_US |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International | * |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | * |
dc.title | In vitro activity of ABT 773, a new ketolide antibiotic, against Chlamydia pneumoniae. | en_US |
dc.type | Article/Review | en_US |
dc.source.journaltitle | Antimicrobial agents and chemotherapy | en_US |
dc.source.volume | 44 | |
dc.source.issue | 4 | |
dc.source.beginpage | 1112 | |
dc.source.endpage | 3 | |
dc.source.country | United States | |
dc.description.version | VoR | en_US |
refterms.dateFOA | 2023-06-30T17:07:25Z | |
html.description.abstract | The in vitro activities of ABT 773, telithromycin (HMR 3647), azithromycin, clarithromycin, erythromycin, and levofloxacin were tested against 20 strains of Chlamydia pneumoniae. The MIC at which 90% of the isolates were inhibited and the minimal bactericidal concentration at which 90% of the isolates were killed by ABT 773 were 0.015 microg/ml (range, 0.008 to 0.015 microg/ml). ABT 773 was the most active antibiotic tested in this study. | |
dc.description.institution | SUNY Downstate | en_US |
dc.description.department | Pediatrics | en_US |
dc.description.degreelevel | N/A | en_US |
dc.identifier.journal | Antimicrobial agents and chemotherapy | |
dc.identifier.issue | 4 | en_US |